Amino acid management of XXXX : a case study.

@entity1 @entity3034 @entity9484 @entity462 @entity17492 @entity935 @entity191 @entity2476 @entity9109 @entity750 @entity1063 @entity669
An extensive list of side effects and problems are associated with the administration of l-dopa ( @entity3034 ) during treatment of @entity191 . These problems can preclude achieving an optimal response with l-dopa treatment. PURPOSE: To present a case study outlining a novel approach for the treatment of @entity191 that allows for management of problems associated with l-dopa administration and discusses the scientific basis for this treatment. @entity1 AND METHODS: The case study was selected from a database containing 254 @entity191 @entity1 treated in developing and refining this novel approach to its current state. The spectrum of @entity1 comprising this database range from newly diagnosed, with no previous treatment, to those who were diagnosed more than 20 years before and had virtually exhausted all medical treatment options. @entity191 is associated with depletion of @entity669 hydroxylase, @entity935 , @entity750 , and @entity1063 . Exacerbating this is the fact that administration of l-dopa may deplete @entity9109 , @entity9484 , @entity2476 ( @entity2476 ), @entity750 , and @entity17492 . The properly balanced administration of l-dopa in conjunction with @entity2476 , @entity9109 , @entity462 , and cofactors under the guidance of organic cation transporter functional status determination (herein referred to as "OCT assay interpretation") of urinary @entity750 and @entity935 , is at the heart of this novel treatment protocol. RESULTS: When @entity2476 and l-dopa are administered in proper balance along with @entity9109 , @entity462 , and cofactors under the guidance of OCT assay interpretation, the long list of problems that can interfere with optimum administration of l-dopa becomes controllable and manageable or does not occur at all. @entity1 treatment then becomes more effective by allowing the implementation of the optimal dosing levels of l-dopa needed for the relief of symptoms without the dosing value barriers imposed by side effects and adverse reactions seen in the past.
